These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17106527)

  • 1. Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors.
    Traşcă E; Buzulică R; Nicolescu I; Traşcă ET
    Rom J Morphol Embryol; 2006; 47(2):175-9. PubMed ID: 17106527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
    Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
    Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
    Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
    Eur J Surg Oncol; 2009 Feb; 35(2):197-201. PubMed ID: 18513919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review. Non-papillary urothelial lesions of the urinary bladder: morphological classification and immunohistochemical markers.
    Petraki CD; Sfikas CP
    In Vivo; 2008; 22(4):493-501. PubMed ID: 18712178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
    Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
    APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular changes in superficial bladder cancer.
    Vrabie CD; Petrescu A; Waller M
    Rom J Morphol Embryol; 2007; 48(2):131-8. PubMed ID: 17641799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):92-7. PubMed ID: 18162775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression.
    Queipo-Zaragoza JA; Ruiz-Cerda JL; Vera-Donoso CD; Vera-Sempere F; Budia-Alba A; Jimenez-Cruz JF
    Scand J Urol Nephrol; 2007; 41(4):283-9. PubMed ID: 17763218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
    Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel p53/p130 axis in bladder tumors.
    Mudryj M; Reay E; Beckett L; Dandekar S; deVere White R; Gandour-Edwards R
    Urology; 2007 Sep; 70(3):608-12. PubMed ID: 17905135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinosarcoma of the urinary bladder. Report of three cases].
    Haj Salah MB; Mekni A; Nouira Y; Haha-Bellil SB; Bellil K; Kchir N; Haouet S; Horchani A; Zitouna M
    Tunis Med; 2007 Nov; 85(11):982-4. PubMed ID: 19166155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail?
    Liedberg F; Anderson H; Chebil G; Gudjonsson S; Höglund M; Lindgren D; Lundberg LM; Lövgren K; Fernö M; Månsson W
    Urol Oncol; 2008; 26(1):17-24. PubMed ID: 18190825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.
    Esuvaranathan K; Chiong E; Thamboo TP; Chan YH; Kamaraj R; Mahendran R; Teh M
    Cancer; 2007 Mar; 109(6):1097-105. PubMed ID: 17311305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.
    Guo CC; Gomez E; Tamboli P; Bondaruk JE; Kamat A; Bassett R; Dinney CP; Czerniak BA
    Hum Pathol; 2009 Oct; 40(10):1448-52. PubMed ID: 19454359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association of NAD(P)H quinone oxidoreductase 1 expression with p53 expression or tumour outcome in patients with superficial and minimally invasive urothelial bladder cancers.
    Mhawech-Fauceglia P; Herrmann FR; Chan A; Cheney RT; Zhang Y
    BJU Int; 2008 Aug; 102(5):639. PubMed ID: 18694413
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.
    Salinas-Sánchez AS; Lorenzo-Romero JG; Giménez-Bachs JM; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-Del-Campo A; Hernández-Millán IR; Segura-Martín M; Atienzar-Tobarra M; Escribano-Martínez J
    Urol Oncol; 2008; 26(6):620-6. PubMed ID: 18367096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.